ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Marin BG, et al. Calciphylaxis and kidney disease: A review. Am J Kidney Dis 2023; 81:232–239. doi: 10.1053/j.ajkd.2022.06.011
-
2.
Wen W, et al. Intravenous sodium thiosulphate for calciphylaxis of chronic kidney disease: A systematic review and meta-analysis. JAMA Netw Open 2023; 6:e2310068. doi: 10.1001/jamanetworkopen.2023.10068
-
3.
Nigwekar SU, et al. Calciphylaxis. N Engl J Med 2018; 378:1704–1714. doi: 10.1056/NEJMra1505292
-
4.
Udomkarnjananun S, et al. Treatment of calciphylaxis in CKD: A systematic review and meta-analysis. Kidney Int Rep 2019; 4:231–244. doi: 10.1016/j.ekir.2018.10.002
-
5.
Sinha S, et al. Hexasodium fytate for the treatment of calciphylaxis: A randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension. EClinicalMedicine 2024; 75:102784. doi: 10.1016/j.eclinm.2024.102784
Calciphylaxis: Hexasodium Fytate as a Potential Treatment for a Devastating Disease
Morgan Hedden
Morgan Hedden
Morgan Hedden, DO, is a nephrology fellow, and C. John Sperati, MD, MHS, is an associate professor of medicine and director of the Nephrology Fellowship Training Program, Division of Nephrology, at the Johns Hopkins University School of Medicine, Baltimore, MD.
Search for other papers by Morgan Hedden in
Current site
Google Scholar
PubMed
Search for other papers by Morgan Hedden in
Current site
Google Scholar
PubMed
C. John Sperati
C. John Sperati
Morgan Hedden, DO, is a nephrology fellow, and C. John Sperati, MD, MHS, is an associate professor of medicine and director of the Nephrology Fellowship Training Program, Division of Nephrology, at the Johns Hopkins University School of Medicine, Baltimore, MD.
Search for other papers by C. John Sperati in
Current site
Google Scholar
PubMed
Search for other papers by C. John Sperati in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory